MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    miR-218-5p Regulates Microglia-mediated Neuroinflammation through Type I Interferon Response in Parkinson’s Disease

    D. Wang, Q. Qin, J. Li, J. Zhao, Z. Mao, Z. Xue (Wuhan, China)

    Objective: To explore the effect of miR-218-5p on microglia activation and dopaminergic neurons damage in mice model of Parkinson's disease(PD) and its potential mechanisms. Background:…
  • 2022 International Congress

    The impact of thyroid disease on severity of motor symptoms in Croatian residents with de novo Parkinson’s disease

    I. Sarac, H. Sarac, F. Borovecki, I. Ivek, L. Bagaric Krakan, Z. Kresic, M. Iveta, T. Sukobljevic (Zagreb, Croatia)

    Objective: The goal of this study was to investigate the association between thyroid disease and severity of motor symptoms in Croatian residents with de novo…
  • 2022 International Congress

    Descriptive case studies of patients in their fifth consecutive year of treatment with ND0612

    A. Espay, A. Ellenbogen, T. Gurevich, R. Case, L. Adar, T. Yardeni, L. Salin (Cincinnati, USA)

    Objective: To describe the long-term experience of three individual patients receiving subcutaneous (SC) levodopa/carbidopa infusion with ND0612 in an open-label clinical safety study. Background: ND0612…
  • 2022 International Congress

    CCL5 promotes Th17 migrating into SNpc by promoting Th17 proportion increase and LFA-1 expression

    XZ. Xue (WuHan, China)

    Objective: To explore the specific pathway by which CCL5 induces Th17 cells migrating into substantia nigra pars compacta (SNpc) to aggravate Parkinson's disease (PD). Background:…
  • 2022 International Congress

    Blood-derived α-synuclein from Parkinson´s disease patients is able to seed pathology

    A. Kluge, J. Bunk, E. Schäffer, H. Knacke, A. Drobny, W. Xiang, R. Lucius, P. Arnold, F. Zunke, D. Berg (Kiel, Germany)

    Objective: To identify seeding capacities of soluble α-synuclein (α-syn) conformers derived from neuronal extracellular vesicles (NEs) from Parkinson´s disease (PD) patients. Background: PD pathology is…
  • 2022 International Congress

    Characteristics and Techniques to Improve Micrographia in Parkinson’s Disease

    S. Shahid (Southampton, USA)

    Objective: To analyze and identify the characteristics found in micrographia and provide methods of improving the symptom. Background: Micrographia, also known as small handwriting, is…
  • 2022 International Congress

    Do clinical neuropsychological tasks capture visuoperceptual deficits in culturally-diverse individuals with Parkinson’s disease and hallucinations?

    S. Adamo, M. Statucka, M. Cohn (Toronto, Canada)

    Objective: To explore whether the Judgement of Line Orientation (JLO), VOSP Silhouettes, and VOSP Object Decision tasks distinguish performance of individuals with Parkinson’s Disease (PD)…
  • 2022 International Congress

    DIFFERENT PATTERNS OF ACUTE SACCADIC RESPONSES TO LEVODOPA CHALLENGE TEST IN DE NOVO PARKINSON’S DISEASE: POSSIBILE PROGNOSTIC IMPLICATIONS

    C. Terravecchia, G. Mostile, CG. Chisari, A. Luca, R. Terranova, G. Donzuso, CE. Cicero, G. Sciacca, A. Nicoletti, M. Zappia (Catania, Italy)

    Objective: To explore possible different patterns of acute saccadic responses to Levodopa Challenge Test (LCT) in a de novo drug-naïve Parkinson’s Disease (PD) population and…
  • 2022 International Congress

    Increased Neutrophil to Lymphocyte Ratio Distinguish Parkinson’s Disease and Parkinson Plus Syndrome

    IH. Kwak, HI. Ma, YE. Kim (Anyang, Republic of Korea)

    Objective: To investigate the peripheral inflammatory markers distinguishing Parkinson’s disease (PD) or Parkinson plus syndrome (PPS). Background: Previous studies had suggested that peripheral inflammation may…
  • 2022 International Congress

    Sweetspot analysis of Deep Brain Stimulation in Parkinson´s disease: Beyond the subthalamic nucleus?

    J. Garcia-Cornet, B. Pascual-Sedano, A. Campolongo, JA. Aibar-Duran, R. Rodriguez-Rodriguez, J. Kulisevsky, I. Aracil-Bolaños (Barcelona, Spain)

    Objective: To study the relationships between clinical response and leads location -in a cohort of Parkinson’s disease (PD) patients and deep brain stimulation of subthalamic…
  • « Previous Page
  • 1
  • …
  • 320
  • 321
  • 322
  • 323
  • 324
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley